Advertisement
UK markets open in 6 hours 55 minutes

  • NIKKEI 225

    38,460.08
    0.00 (0.00%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.70
    -0.11 (-0.13%)
     

  • GOLD FUTURES

    2,327.90
    -10.50 (-0.45%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,590.88
    -1,794.77 (-3.36%)
     

  • CMC Crypto 200

    1,388.25
    -35.85 (-2.52%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Natera (NTRA) Q1 2020 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·36-min read
Natera (NTRA) Q1 2020 Earnings Call Transcript

Ladies and gentlemen, thank you for joining us for the Natera, Inc. first-quarter 2020 earnings conference call. Also on the line is Steve Chapman, our CEO; Bob Schueren, chief operating officer; Solomon Moshkevich, general manager of oncology; and Paul Billings, chief medical officer. During the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our operational and financial outlook, our assumptions for that outlook, the impact of the COVID-19 pandemic on our business and operations, market size and partnerships, clinical studies, opportunities and strategies and expectations for various current and future products, including product capabilities, expected release dates, reimbursement coverage and related effects on our financial and operating results.

Continue reading